Evolving technologies include modification of receptors on T cells to better target tumor microenvironments and minimize off-tumor cross-reactivity.
Fiona Thistlethwaite
Advertisement
Articles by Fiona Thistlethwaite
Advertisement
Latest Updated Articles
- Facilitating Adoptive Cell Therapy Clinical Trials
December 9th 2020
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Evolution of Preclinical CRO Strategic Partnerships: From Transactional Services to Value-Driven Ecosystems in 2026
2
The Execution Gap: Why Clinical Trial Infrastructure Has to Be Built Before AI Can Deliver
3
ACT Brief: Epilepsy Trial Feasibility and Family Realities, CRO Partnerships and Strategic Value, and Cortisol and GLP-1 Response
4
How Clinical Teams Can Build Real Trust With Patient Advocacy Organizations
5